Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck
• Wall Street JournalShionogi starts human trials for a once-a-day drug designed to neutralize the coronavirus in less than a week
Shionogi starts human trials for a once-a-day drug designed to neutralize the coronavirus in less than a week